New progress in iron chelation therapy

研究成果: Article同行評審

摘要

Iron is required for many enzymes which are critical for cellular functions and plays an important role in oxygen carrying proteins, e.g. hemoglobin. But it can be toxic when present in excess. Therefore, the total body iron store should be kept within defined limits. When there is excess of iron in the body, it is called iron overload. If it is untreated, it will damage the target organs, including the heart, liver and endocrine organs. Clinically we can use phlebotomy or iron chelators to treat iron overload. In the past 3 or 4 decades, only one available iron chelator "deferoxamine" can be used. However, poor compliances and inconvenience are major problems. During the past few years the advances on iron chelation research has been impressive, leading to the development of new oral iron chelators including deferiprone and deferasirox. The new treatment options greatly enhance the efficacy of iron chelation for preventing and treating the iron overload complications. Whichever iron chelator is chosen, patients should be closely monitored both for effectiveness of therapy and for toxic side effects.

原文English
頁(從 - 到)48-57
頁數10
期刊Journal of Internal Medicine of Taiwan
20
發行號1
出版狀態Published - 2009 二月 1

All Science Journal Classification (ASJC) codes

  • 內科學

指紋

深入研究「New progress in iron chelation therapy」主題。共同形成了獨特的指紋。

引用此